SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU.X is trending due to the strong sense of community and the increasing number of holders, with many emphasizing the project's real-world applications like merchandise and events. Community members highlight the coin's potential for long-term growth and its unique position as a permissionless brand. The community's active involvement and constant building efforts are also driving interest.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending as traders weigh the potential impact of a looming government shutdown and await key jobs data, with some anticipating a market dip. Community chatter reflects uncertainty, with discussions around potential market manipulation and the sustainability of current valuations. Broader market themes include the influence of AI, precious metals performance, and Trump's economic policies.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as investors discuss the upcoming warrant distribution in early October and its potential impact on short positions. The community is speculating on potential price movements and the possibility of a short squeeze related to the warrants. Chatter around a Wedbush analyst ending coverage, the video game sector, and any potential news from Roaring Kitty are also driving conversation.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community rallies around its commitment to long-term growth and continued development. A recent mention in Forbes has increased visibility, and the community is actively promoting the coin's unique culture and upcoming utilities. Discussions focus on the coin's resilience and the team's dedication to building a lasting project on the Solana blockchain.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Despite recent positive news and a major deal with OpenAI, CRWV is trending due to high volatility and a significant price drop, sparking debate about market manipulation and long-term sustainability. Community members are actively discussing dip-buying strategies, potential for a short squeeze, and the impact of insider selling. The broader context includes the AI infrastructure sector's growth potential and CRWV's relationship with NVIDIA.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as traders discuss potential government shutdowns and their impact on the market, with some bracing for a correction while others remain bullish. Community members are actively debating technical indicators and market momentum, especially regarding tech and chip stocks. A possible lighter regulation from the SEC is adding to the conversation.

Jupiter is a cryptocurrency exchange platform on the Solana blockchain, offering features such as token swapping, limit orders, dollar-cost averaging, and a bridge for asset transfers to Solana. It provides users with tools to find the best trading prices and includes a beta version for perpetual futures trading. Jupiter finds the best price route for your swap by aggregating all the major liquidity sources on Solana.

Jupiter

Jupiter is trending as community members highlight $UPDOG, a Solana-based meme coin available on Jupiter's strict list. The community buzz revolves around loading up on $UPDOG, emphasizing its longevity and community-driven nature within the Solana ecosystem. Many promote swapping $SOL for $UPDOG using Jupiter's platform.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics is trending following positive Phase 3 trial data for their skin drug, sonelokimab, which is showing promising results in treating hidradenitis suppurativa. Community discussions revolve around the drug's efficacy and safety profile compared to competitors, as well as speculation regarding potential buyout offers and long-term gains. Some traders are concerned about a possible high placebo response and potential profit-taking despite overall optimism for MoonLake's future.

Codatta

Codatta ($XNY.X) is trending amid discussions about its on-chain fingerprint verification feature and potential applications in AI and data utility. The community is analyzing chart patterns and anticipating new highs, with some highlighting its strength in the market. Technical analysis suggests a bullish Elliott Wave structure, contingent on maintaining key support levels.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation ($ACHR) is trending as the company achieves new milestones in its flight test program, with community members discussing the potential for significant gains and comparing it to sector peer Joby Aviation ($JOBY). Investors are closely watching for key technical levels to be broken and anticipating news, particularly around piloted flights and defense contracts, which could serve as catalysts. Discussions also involve the stock's high short interest and potential for a short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Alnylam (ALNY) Surges 6.0%: Is This an Indication of Further Gains?

Alnylam (ALNY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Wall Street Analysts Predict a 130.63% Upside in Foghorn Therapeutics (FHTX): Here's  What You Should Know

The mean of analysts' price targets for Foghorn Therapeutics (FHTX) points to a 130.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies IQVIA and Flagship Pioneering Announce Strategic Collaboration to...

Is Arcutis Biotherapeutics (ARQT) Stock Outpacing Its Medical Peers This Year?

Here is how Arcutis Biotherapeutics, Inc. (ARQT) and Foghorn Therapeutics Inc. (FHTX) have performed compared to their sector so far this year.

Foghorn Therapeutics (FHTX) Upgraded to Buy: Here's Why

Foghorn Therapeutics (FHTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Here's Why Foghorn Therapeutics (FHTX) Looks Ripe for Bottom Fishing

Foghorn Therapeutics (FHTX) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Lags Revenue Estimates

Foghorn Therapeutics (FHTX) delivered earnings and revenue surprises of +9.68% and -0.85%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

NovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates

NovoCure (NVCR) delivered earnings and revenue surprises of +7.69% and +3.24%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Foghorn Therapeutics Inc. (FHTX) Reports Q1 Loss, Misses Revenue Estimates

Inovio Pharmaceuticals (INO) Reports Q1 Loss, Tops Revenue Estimates

Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology. Through its scalable Gene Traffic Control product platform, the firm is systematically interrogating and drugging the chromatin regulatory system. The company was founded by Cigall Kadoch, Gerald W. Crabtree and Douglas G. Cole in October 2015 and is headquartered in Cambridge, MA.

Foghorn Therapeutics Inc

Will the U.S. government shut down in 2025? 
 
*Powered by Polymarket

Current Price	$4.86
Prev Close	$4.69
Open	$4.69
Dividend Yield	0.00%
50-Day Moving Average	$5.30
Beta	1.58
Avg. Volume	92,514.57
PE Ratio	-3.92

52-Week High	$9.85
52-Week Low	$2.94
Market Capitalization	$274.74M
EPS (Annual)	-$1.58
Price to Book	-3.54
Revenue Per Employee	$201,803.57
Enterprise Value/EBITDA	N/A

FHTX
Foghorn Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest FHTX News

FHTX Foghorn Therapeutics Inc